Prevalence of hopelessness and suicidal ideation and their associated factors among pediatric patients with leukemia - Zekavat OR, Safari N, Sahraian A, Bordbar M, Pakniyat A, Bozorgi H.
With the increasing survival rate of pediatric patients with leukemia, improving their quality of life (QoL) is the new challenge. Psychiatric disorders are among the significant confounding factors of the aforementioned patients' QoL. Ninety-seven pediatr... (Source: SafetyLit)
Source: SafetyLit - October 2, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Star Of Downton Abbey, ‘Four Weddings And A Funeral’ Announces Her Daughter’s Death
British actress Anna Chancellor has paid loving tribute to her daughter Poppy, who has died from leukaemia. Chancellor, who starred in Four Weddings and a Funeral and also appeared in Downton Abbey, posted a message on Saturday announcing the death of her daughter, an illustrator and artist, the…#fourweddings #funeral #downtonabbey #poppy #dailymail #hitchhikersguide #galaxy #pride #bafta #olivier (Source: Reuters: Health)
Source: Reuters: Health - October 1, 2023 Category: Consumer Health News Source Type: news
Syndax to Announce Topline Results from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia and Host an Investor Call on October 2, 2023
WALTHAM, Mass., Sept. 29, 2023 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will host a conference call and live webcast to share topline results from the... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 29, 2023 Category: Pharmaceuticals Tags: TRI CCA Source Type: news
Leukemia Research Foundation Awards $2.4M in Research Grants
The Leukemia Research Foundation is pleased to award $2.4M in research grants through its 2023 New Investigator Research Grant Program. The16 awardees are all new investigators from leading institutions from around the world, and have identified projects that have the potential to impact... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 29, 2023 Category: Pharmaceuticals Tags: AWD NPT Source Type: news
Mum gets gut-wrenching leukemia diagnosis after kid's doctor spotted one thing
Laura Hendricks learned she had acute myeloid leukemia at the age of 40 after taking her sick children for a routine visit to the pediatrician. (Source: Daily Express - Health)
Source: Daily Express - Health - September 29, 2023 Category: Consumer Health News Source Type: news
Stowmarket double cancer survivor, 21, backs leukaemia campaign
Jake Andrade has had a rare type of the blood cancer twice since he was 13-years-old. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 29, 2023 Category: Consumer Health News Source Type: news
Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screening
(MedPage Today) -- Despite ongoing efforts to overcome shortages of cancer drugs, many hospitals report critically low supplies of drugs to treat leukemia and lymphoma in children. (NBC News)
Reluctantly, AstraZeneca, Bristol Myers Squibb, and... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 28, 2023 Category: Hematology Source Type: news
Episode 5: Monitoring and Diagnostics in Chronic Myeloid Leukemia Episode 5: Monitoring and Diagnostics in Chronic Myeloid Leukemia
Drs Michael J. Mauro and Jerald P. Radich discuss monitoring and diagnostics in chronic myeloid leukemia, including the Philadelphia chromosome and how it plays into the current treatment of CML.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
FDA Approves Bosutinib for Pediatric Patients with Chronic Myelogenous Leukemia
September 27, 2023 -- On September 26, 2023, the Food and Drug Administration approved bosutinib (Bosulif, Pfizer) for pediatric patients 1 year of age and older with chronic phase (CP) Ph+ chronic myelogenous leukemia (CML) that is newly diagnosed... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 27, 2023 Category: Drugs & Pharmacology Source Type: news
Leukemia Research Foundation Earns Highest Distinction from Charity Navigator
The Leukemia Research Foundation, a nonprofit headquartered in Northfield, IL, has earned the highest possible rating of four stars from Charity Navigator, America's largest independent charity evaluator. This is the fifth time the Leukemia Research Foundation has earned this top... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 27, 2023 Category: Pharmaceuticals Tags: AWD NPT Source Type: news
FDA Approves Bosutinib for Children With CML FDA Approves Bosutinib for Children With CML
The agency approved the tyrosine kinase inhibitor for pediatric patients with chronic phase Ph+ chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
How Targeted Drugs Can Vanquish a Virulent Leukemia How Targeted Drugs Can Vanquish a Virulent Leukemia
A new era of targeted therapy is improving prognoses somewhat and raising hopes that even bigger advancements are on the horizon.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 26, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Frontline Combo Yields High Remission Rate in Hairy Cell Leukemia
(MedPage Today) -- Use of the BRAF inhibitor vemurafenib (Zelboraf) combined with the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) led to high rates of complete remission as frontline therapy for patients with hairy cell leukemia in a small... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 26, 2023 Category: Hematology Source Type: news
Niche Interactions Lock Down Leukemia Cells
Researchers unravel the mystery of epithelial to mesenchymal transition in acute lymphoblastic leukemia with co-culture techniques, CRISPR-screening, and RNA sequencing. (Source: The Scientist)
Source: The Scientist - September 24, 2023 Category: Science Tags: News News & Opinion Source Type: news
Proteinuria Higher With Dasatinib Exposure in Chronic Myelogenous Leukemia
WEDNESDAY, Sept. 20, 2023 -- For patients with chronic myelogenous leukemia (CML) receiving tyrosine-kinase inhibitor therapy, exposure to dasatinib is associated with increased odds of proteinuria, according to a study published online in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news
